Abstract BackgroundDefine the effectiveness of a topical non-steroidal anti-inflammatory drug (NSAID) added to topical steroid use after uncomplicated phacoemulsification for the prevention of pseudophakic cystoid macular edema (PCME) using a prospective, randomized, double-masked, placebo-controlled clinical study. MethodsEyes (1000) were randomized to placebo (497) or nepafenac 0.3% (503) used once daily, post-operatively for 5Â weeks at two ophthalmology clinics. Diagnosis of PCME was made by clinical, ocular coherence tomography (OCT), and with fluorescein angiography confirmation. Correlation of PCME to NSAID use and the presence of pre-operative risk factors for PCME were assessed including, contralateral PCME, diabetic retinopathy, retinal vein occlusion, macular hole, epiretinal membrane, macular degeneration, retinal detachment repair, and prostaglandin use. ResultsPCME was the most common complication associated with routine cataract surgery (4.2% with PCME risk factors, 2.0% with risk factors excluded). Topical nepafenac 0.3% significantly reduces the incidence of PCME compared to placebo when used after routine cataract surgery (p = .0001). When patients with pre-operative risk factors are excluded, the incidence of PCME between treatment and placebo groups is equivalent (p = 0.31). PCME relative risk (RR) was most significant in contralateral PCME (RR 19.5), diabetic retinopathy (RR 13.1), retinal vein occlusion (RR 12.9), macular hole (RR 7.7), and epiretinal membrane (RR 5.7). Prostaglandin use and previous retinal detachment were not shown to increase risk. ConclusionPseudophakic cystoid macular edema is common after phacoemulsification cataract surgery. Topical nepafenac 0.3% reduces PCME in patients with pre-operative risk factors for PCME compared to placebo but shows no benefit in patients without pre-operative risk factors. Trial registrationNIH ClincalTrials.gov retrospectively registered January 15, 2017, NCT03025945.
diabetic retinopathy1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Diabetic_retinopathy  

cataract surgery              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cataract_surgery      

relative risk                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Relative_risk         

cystoid macular edema         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_edema         

placebo                       0.9999999999456577^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Placebo               

placebo                       0.9999999999456577^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Placebo               

epiretinal membrane           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Epiretinal_membrane   

pseudophakic                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Intraocular_lens      

prostaglandin                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Prostaglandin         

macular degeneration          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_degeneration  

contralateral                 0.9999999958254193^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Anatomical_terms_of_location

non-steroidal anti-inflammatory drug1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Non-steroidal_anti-inflammatory_drug

cystoid macular edema         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_edema         

epiretinal membrane           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Epiretinal_membrane   

retinal detachment            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retinal_detachment    

NSAID                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Non-steroidal_anti-inflammatory_drug

NSAID                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Non-steroidal_anti-inflammatory_drug

cataract surgery              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cataract_surgery      

phacoemulsification           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Phacoemulsification   

retinal detachment            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Retinal_detachment    

tomography                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/X-ray_computed_tomography

ophthalmology                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Ophthalmology         

macular hole                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_hole          

contralateral                 0.9999999958254193^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Anatomical_terms_of_location

incidence                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Incidence_(epidemiology)

placebo                       0.9999999999456577^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Placebo               

cataract surgery              1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cataract_surgery      

fluorescein angiography       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Fluorescein_angiography

phacoemulsification           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Phacoemulsification   

macular hole                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Macular_hole          

diabetic retinopathy          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Diabetic_retinopathy  

placebo                       0.9999999999456577^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Placebo               

retinal vein occlusion        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Central_retinal_vein_occlusion

retinal vein occlusion        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Central_retinal_vein_occlusion

incidence                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Incidence_(epidemiology)

topical steroid               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Topical_steroid       

